NINDS invites applications for its cooperative program in translational research. This announcement is supported by 4 funding mechanisms: U01, U24, U44, and U54.
Opportunities for discovery and progress in treating neurological diseases have never been greater. Remarkable advances have been made recently in understanding the molecular and genetic bases of disease. The potential therapies offered by these scientific findings create an opportunity for basic, applied, and clinical scientists to combine and coordinate their efforts. Recent discoveries across a broad range of neuroscience research areas offer promising opportunities for treating neurological disorders. As part of its mission to reduce the burden of neurological disease, NINDS is committed to encouraging the translation of these discoveries into new treatments.
Potential applicants should contact Dr. Thomas Miller, program director, Technology Development Group, NINDS; telephone: 301-496-1779; email: email@example.com. For more information visit http://grants.nih.gov/grants/guide/pa-files/PAR-08-233.html, http://grants.nih.gov/grants/guide/pa-files/PAR-08-234.html, http://grants.nih.gov/grants/guide/pa-files/PAR-08-235.html, or http://grants.nih.gov/grants/guide/pa-files/PAR-08-236.html.